13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001835943
Total reported value
$1.6B
$1.6B
39 檔
13.1%
In Q3 2024, AIGH Capital Management LLC's U.S. equity holdings reached a combined market value of $1.6B, distributed across 39 disclosed stock positions.
AIGH Capital Management LLC executed strategic sector rebalancing during Q3 2024, establishing 10 new positions while fully exiting 9 holdings and trimming 10 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 31.15% | — | -50.00% | |
| 2 | GLW | Corning Inc | Stock-Tech | 11.46% | — | — | |
| 3 | PSNL | Personalis Inc | Stock-Other | 6.07% | -1.07% | — | |
| 4 | SCPH | Scpharmaceuticals Inc | Stock-Other | 5.30% | — | +17.69% | |
| 5 | ARQ | Arq Inc | Stock-Other | 4.66% | — | +31.51% | |
| 6 | DCTH | Delcath Systems Inc | Stock-Other | 4.54% | — | -25.72% | |
| 7 | APPS | Digital Turbine Inc | Stock-Other | 3.89% | +3.40% | — | |
| 8 | MYO | Myomo Inc | Stock-Other | 3.14% | — | -4.77% | |
| 9 | ✓ | Biodesix Inc | Stock-Other | 2.85% | — | -1.73% | |
| 10 | ELUT | Elutia Inc | Stock-Other | 2.70% | -0.34% | +47.91% | |
| 11 | CLRBUSD | Cellectar Biosciences Inc | Stock-Other | 1.93% | — | +5.31% | |
| 12 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 1.90% | — | — | |
| 13 | TELA | Tela Bio Inc | Stock-Other | 1.76% | — | +49.06% | |
| 14 | XERS | Xeris Biopharma Holdings Inc | Stock-Other | 1.76% | — | — | |
| 15 | BKTI | Bk Technologies CORP | Stock-Other | 1.74% | -0.33% | EXIT | |
| 16 | IPWR | Ideal Power Inc | Stock-Other | 1.62% | -0.16% | — | |
| 17 | ELVA | Electrovaya Inc | Stock-Other | 1.61% | — | -4.96% | |
| 18 | LPTH | Lightpath Technologies Inc-a | Stock-Other | 1.44% | -0.14% | EXIT | |
| 19 | TQ80 | Theratechnologies Inc | Stock-Other | 1.30% | — | — | |
| 20 | EGRX | Eagle Pharmaceuticals Inc | Stock-Other | 1.27% | — | — | |
| 21 | COYA | Coya Therapeutics Inc | Stock-Other | 1.18% | -0.29% | — | |
| 22 | IDN | Intellicheck Inc | Stock-Other | 1.08% | -1.45% | EXIT | |
| 23 | ✓ | Polypid LTD | Stock-Other | 0.67% | -0.47% | +41.82% | |
| 24 | MRAM | Everspin Technologies Inc | Stock-Other | 0.62% | — | — | |
| 25 | MX | Magnachip Semiconductor CORP | Stock-Other | 0.59% | — | — | |
| 26 | ✓ | Stock-Other | 0.54% | — | — | ||
| 27 | FKWL | Franklin Wireless CORP | Stock-Other | 0.50% | — | — | |
| 28 | IMMX | Immix Biopharma Inc | Stock-Other | 0.47% | — | -20.12% | |
| 29 | APRE | Aprea Therapeutics Inc | Stock-Other | 0.42% | -0.06% | — | |
| 30 | ✓ | Beyond Air Inc | Stock-Other | 0.39% | — | -0.99% | |
| 31 | KPRX | Kiora Pharmaceuticals Inc | Stock-Other | 0.26% | — | -0.00% | |
| 32 | ✓ | Stock-Other | 0.25% | — | — | ||
| 33 | CYTXEUR | Plus Therapeutics Inc | Stock-Other | 0.23% | — | -1.37% | |
| 34 | BFRI | Biofrontera Inc | Stock-Other | 0.19% | -0.06% | — | |
| 35 | SMTK | Smartkem Inc | Stock-Other | 0.16% | -0.03% | EXIT | |
| 36 | INABEUR | In8bio Inc | Stock-Other | 0.13% | — | -21.30% | |
| 37 | MCHX | Marchex Inc-class B | Stock-Other | 0.10% | — | — | |
| 38 | EVOK | Evoke Pharma Inc | Stock-Other | 0.10% | — | — | |
| 39 | SVREW | Saverone 2014 LTD -cw27 | Stock-Other | 0.01% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GLW | Corning Inc | +11.5% | NEW | New buy |
| 2 | PSNL | Personalis Inc | +6.1% | NEW | New buy |
| 3 | APPS | Digital Turbine Inc | +3.9% | NEW | New buy |
| 4 | XBI | Ss Spdr S&p Biotech ETF | +2.3% | -50.00% | Trim |
| 5 | TARS | Tarsus Pharmaceuticals Inc | +1.9% | NEW | New buy |
| 6 | XERS | Xeris Biopharma Holdings Inc | +1.8% | NEW | New buy |
| 7 | MRAM | Everspin Technologies Inc | +0.6% | NEW | New buy |
| 8 | ARQ | Arq Inc | +0.6% | +31.51% | Add |
| 9 | BKTI | Bk Technologies CORP | +0.6% | — | Unchanged |
| 10 | MX | Magnachip Semiconductor CORP | +0.6% | NEW | New buy |
| 11 | SCPH | Scpharmaceuticals Inc | +0.6% | +17.69% | Add |
| 12 | ✓ | +0.3% | NEW | New buy | |
| 13 | MYO | Myomo Inc | +0.2% | -4.77% | Trim |
| 14 | ✓ | Biodesix Inc | +0.1% | -1.73% | Trim |
| 15 | MCHX | Marchex Inc-class B | +0.1% | NEW | New buy |
| 16 | EVOK | Evoke Pharma Inc | +0.1% | NEW | New buy |
| 17 | ELUT | Elutia Inc | +0.1% | +47.91% | Add |
| 18 | IPWR | Ideal Power Inc | +0.1% | — | Unchanged |
| 19 | FKWL | Franklin Wireless CORP | +0.1% | — | Unchanged |
| 20 | BFRI | Biofrontera Inc | +0.1% | — | Unchanged |
| 21 | ✓ | Polypid LTD | 0% | +41.82% | Add |
| 22 | SVREW | Saverone 2014 LTD -cw27 | — | — | Unchanged |
| 23 | LPTH | Lightpath Technologies Inc-a | 0% | — | Unchanged |
| 24 | CYTXEUR | Plus Therapeutics Inc | 0% | -1.37% | Trim |
| 25 | COYA | Coya Therapeutics Inc | -0.1% | — | Unchanged |
| 26 | ✓ | -0.1% | — | Unchanged | |
| 27 | KPRX | Kiora Pharmaceuticals Inc | -0.1% | -0.00% | Trim |
| 28 | SMTK | Smartkem Inc | -0.1% | — | Unchanged |
| 29 | VCNX | Vaccinex Inc | -0.1% | EXIT | Sold out |
| 30 | EVOKEUR | Evoke Pharma Inc | -0.1% | EXIT | Sold out |
| 31 | CGTX | Cognition Therapeutics Inc | -0.2% | EXIT | Sold out |
| 32 | CLRBUSD | Cellectar Biosciences Inc | -0.2% | +5.31% | Add |
| 33 | ✓ | Beyond Air Inc | -0.2% | -0.99% | Trim |
| 34 | APRE | Aprea Therapeutics Inc | -0.3% | — | Unchanged |
| 35 | TQ80 | Theratechnologies Inc | -0.3% | — | Unchanged |
| 36 | IMMX | Immix Biopharma Inc | -0.4% | -20.12% | Trim |
| 37 | INABEUR | In8bio Inc | -0.4% | -21.30% | Trim |
| 38 | ELVA | Electrovaya Inc | -0.5% | -4.96% | Trim |
| 39 | ZVRA | Zevra Therapeutics Inc | -0.5% | EXIT | Sold out |
| 40 | TELA | Tela Bio Inc | -0.7% | +49.06% | Add |
| 41 | IDN | Intellicheck Inc | -0.8% | — | Unchanged |
| 42 | EGRX | Eagle Pharmaceuticals Inc | -0.8% | — | Unchanged |
| 43 | PROF | Profound Medical CORP | -1.7% | EXIT | Sold out |
| 44 | DCTH | Delcath Systems Inc | -1.7% | -25.72% | Trim |
| 45 | RCAT | Red Cat Holdings Inc | -1.8% | EXIT | Sold out |
| 46 | INFNEUR | Infinera CORP | -6.4% | EXIT | Sold out |
| 47 | SIMO | Silicon Motion Technol-adr | -6.9% | EXIT | Sold out |
| 48 | WDC | Western Digital CORP | -7.1% | EXIT | Sold out |
According to official SEC Form 13F filings, AIGH Capital Management LLC reported a total U.S. public equity portfolio value of $1.6B across 39 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including XBI, GLW, PSNL) accounted for 13.1% of total reported equity market value during Q3 2024.
Top New Position Initiated
GLW
市值: $40.6M
Top Position Liquidated / Trimmed
WDC
前期市值: $22.7M
During Q3 2024, AIGH Capital Management LLC's top holdings by market value included XBI (31.1%)、GLW (11.5%)、PSNL (6.1%). The largest single position, XBI, represented 31.1% of total portfolio value.
In Q3 2024, AIGH Capital Management LLC made 35 total portfolio adjustments, initiating 10 new buys, adding to 6 positions, trimming 10 holdings, and fully liquidating 9 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.